Founded in 2005, Laurus Labs is a research-driven pharmaceutical and biotechnology company with an aim to improve the quality of life for millions of people around the world.

Laurus has a global leadership position in select active pharmaceutical ingredients (APIs) including anti-retroviral, oncology drugs (incl. highly potent APIs), cardiovascular, and gastro therapeutics. Laurus also offers integrated Contract Development and Manufacturing Organization (CDMO) services to Global Innovators from the clinical phase drug development to commercial manufacturing.

Laurus is passionate about continuous technological advances for smart and green chemistry technologies to drive efficiencies and sustainable manufacturing backed by proven regulatory and quality foundation. Laurus employees 6,972 people including 2,586 personnel working at R&D at more than 15 facilities approved by global agencies USFDA, WHO-Geneva, Japan-PDMA, UK-MHRA, EMA, TGA etc.

During FY2023, Laurus generated ₹ 6,041 crore in annual revenue and is listed on the BSE (Bombay Stock Exchange) and the NSE (National Stock Exchange) in India. Laurus’ proactive stance to conduct business with utmost transparency, integrity and respect for environment & communities have earned it a place in governance benchmark, consistently Certified Great Place to Work and Rated “BBB” by leading MSCI ESG Ratings.